Reported 7 months ago
Tempus AI Inc., a technology platform company using artificial intelligence to process medical data, priced its IPO at $37 per share to raise $410.7 million. With a market value of $6.1 billion, Tempus AI facilitates 'intelligent diagnostics' for precision medicine by connecting lab results to patient clinical data, used by over 7,000 physicians. Founded in 2015, the company had a net loss of $214 million on revenue of $532 million in 2023. Led by Morgan Stanley, JPMorgan Chase & Co., and Allen & Co., the IPO will trade on the Nasdaq under the symbol TEM.
Source: YAHOO